ÂÜÀòÂÒÂ×

Eitan Dekel is a Managing Director at Orbia Ventures since March 2019, with extensive experience in investment and advisory roles across various companies. Currently, Eitan serves as an Investor for Type One Energy Group, Deepomatic, Verdagy, and Silvec Biologics, and holds positions as a Board Member for Ascend Elements and QART Medical, among others. Eitan has expertise in consulting for investment firms and startups since 2017. Educational qualifications include an MBA from The University of Manchester, a BSc in Electrical Engineering from Technion - Israel Institute of Technology, and completion of coursework at Stanford University Graduate School of Business in 2019.